Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: Life, scope, and value Sverre E. KjeldsenArne S. WestheimIngrid Os Invited Commentary Pages: 155 - 157
Is hypertension a prothrombotic state? George I. VarugheseGregory Y. H. Lip OriginalPaper Pages: 168 - 173
New-onset diabetes in treated hypertensive patients Paolo VerdecchiaFabio AngeliRoberto Gattobigio OriginalPaper Pages: 174 - 179
Alcohol consumption and hypertension Michael HuntgeburthHenrik ten FreyhausStephan Rosenkranz OriginalPaper Pages: 180 - 185
Aldosterone antagonism: An emerging strategy for effective blood pressure lowering Monique N. Pratt-UbunamaMari K. NishizakaDavid A. Calhoun OriginalPaper Pages: 186 - 192
Prolonged activation of the baroreflex: A viable approach for the treatment of hypertension? Thomas E. LohmeierAustin M. BarrettEric D. Irwin OriginalPaper Pages: 193 - 198
Aldosterone receptor antagonists: Biology and novel therapeutic applications Paolo MagniMarcella Motta OriginalPaper Pages: 206 - 211
Hypertension in patients with cushing’s disease: Pathophysiology, diagnosis, and management Alan SacerdoteKarolina WeissSamy I. McFarlane OriginalPaper Pages: 212 - 218
Challenges in the diagnosis and management of renal artery stenosis Moro O. SalifuDhiren M. HariaSamy I. McFarlane OriginalPaper Pages: 219 - 227